Back
August 3, 2022

A Tribute to All the “Quixotes” who have Challenged the Mass COVID Vaccination Campaign

A Tribute to All the “Quixotes” who have Challenged the Mass COVID Vaccination Campaign

To all who have dared to challenge the mass COVID vaccination campaign,
THANK YOU!

Note: There is a North American view of Quixote and a Latin American view---the latter representing a more accurate interpretation of what Cervantes meant (in my opinion).  

In North America, Quixote is stereotypically viewed as a lovable, well-meaning person who is humorously out-of-touch with reality. A person who foolishly believes in human goodness and, with paranoid zeal, tries to correct wrongs.  

In Latin America, Quixote is a symbol of people who, thankfully, are “crazy” enough to believe in human goodness and the need to enthusiastically correct wrongs.  In Latin America, it is deemed foolish and paranoid to not believe in human goodness and to not seek correction of wrongs.

Sancho deeply admired Quixote.  He did not fully understand Quixote and had reservations about Quixote’s actions and decisions, but he intuitively recognized that there was something special, true, and important about Quixote.  In that sense, Sancho was much wiser and more admirable than the purveyors of the mass COVID vaccination campaign.  

Rob Rennebohm, MD

Website: notesfromthesocialclinic.org

July 29, 2022

Daumier’s Depictions of Don Quixote

Quixote: Thinking, questioning, worrying, connecting the dotsSancho: sleeping

Quixote: Riding resolutely forward; Sancho: lagging far behind

Quixote: Fearlessly charging into daunting, uncharted territorySancho: Afraid to follow

Quixote: Pushing forward - Sancho: Pushing backward

It’s getting late; the sun is setting - Quixote: continues on - Sancho: catching up, but not fast enough

Quixote: Taking a deep dive into the literature; relentlessly learning; marveling at the complexity; relaxed, comfortable, and confident; still thinking

Let’s not forget the “art of Medicine”
Support our work
DONATE
Subscribe to our Substack Newsletter

Dr. Rennebohm is a pediatrician and pediatric rheumatologist.  He is currently largely retired.  In 2018 he officially retired from the pediatric rheumatology department at Cleveland Clinic, where he was also the Director of the International Susac Syndrome Consultation Service (2012-2018). Prior to that, he was at Alberta Children’s Hospital in Calgary, Canada, where he was Clinical Professor of Pediatrics and Pediatric Rheumatology (2008-2012); before that he was at Nationwide Children’s Hospital and Ohio State University in Columbus, Ohio, where he was Associate Professor of Pediatrics and Chief of Pediatric Rheumatology for 21 years; and before that he was a pediatric rheumatologist at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio.

He went to medical school at the University of California San Diego (UCSD), at La Jolla, where he graduated with an MD degree in 1972.   He completed his Pediatric Residency training at IWK Children’s Hospital/Dalhousie University in Halifax, Nova Scotia.  He completed his Pediatric Rheumatology Fellowship training at Cincinnati Children’s Hospital Medical Center  He has been a pediatrician for almost 50 years and a pediatric rheumatologist for about 42 years.  

Although he is no longer in clinical practice or affiliated with a medical school or health care institution, he has continued his intense interests in pediatric rheumatology, Susac syndrome, and now COVID.  In fact, throughout the past 2 years he has spent many hours per day on most days of most weeks intensively studying and writing about COVID---because he has realized how profoundly important and complex the COVID situation is.

He currently lives in Seattle, Washington.  His clinical pediatrics activity is now limited to being on “first pediatric call” for his 9 grandchildren.

Recent Posts
December 2, 2024

Are Newly Emerging Saltation Variants the Desperate Harbingers of an Imminent Surge in COVID-19 Case Fatalities in Highly C-19 Vaccinated Populations?

Read
November 23, 2024

Bird Flu Gain-of-Function Study Fueling Vaccine Development, Fears of Human Transmission

Read
November 23, 2024

De kak van Knack

Read
Voices for Science and solidarity, © 2023